Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?

Autor: Essel, Kathleen G., Bruegl, Amanda, Gershenson, David M., Ramondetta, Lois M., Naumann, R. Wendel, Brown, Jubilee

Publikováno v: In Gynecologic Oncology July 2017 146(1):74-80

Safety Profile of Mirvetuximab Soravtansine, a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Patients with Recurrent Ovarian Cancer

Autor: Essel, Kathleen G., Martin, Lainie P., O’Malley, David M., Matulonis, Ursula, Konner, Jason A., Birrer, Michael J., Moore, K.N.

Publikováno v: In Gynecologic Oncology March 2020 156(3):e15-e16

Association of financial assistance programs and time to completion of therapy in women receiving chemoradiation for cervical cancer.

Autor: Gillen JM; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Grimes SC; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Essel KG; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Duininck GE; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Zhao D; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Thompson JS; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Richardson DL; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA.

Publikováno v: Gynecologic oncology reports [Gynecol Oncol Rep] 2020 Oct 21; Vol. 34, pp. 100660. Date of Electronic Publication: 2020 Oct 21 (Print Publication: 2020).